- Treatment with ECUR-506 resulted in a complete clinical response from three months post exposure to the end of study (six months post exposure) - ECUR-506 was generally well tolerated with no significant clinical safety concerns - Insertion of a functional OTC gene through ARCUS in vivo gene...
